Background: The culture of retinal progenitors from an accessible adult stem cell source such as the limbus could provide a useful autologous source of retinal cell therapies. The human corneoscleral limbus contains multipotent stem cells that can be cultured as floating neurospheres. Previous work in rodents has demonstrated neuronal and photoreceptor differentiation from limbal neurosphere cultures. Here, this study has examined undifferentiated cultured adult human limbal neurospheres as donor cells for retinal cell therapies by transplantation into a rat model of retinal degeneration.
Methods: Gene expression in limbal neurospheres was examined by immunostaining and western blot. Human limbal neurospheres were transplanted into the subretinal space of Royal College of Surgeon's rats. Rats were monitored by optical coherence tomography for 6 weeks then processed for retinal histology.
Results: Human limbal neurospheres expressed the neural lineage markers, Nestin, sex determining region box-2 and N-cadherin, and the retinal transcription factors microphthalmia-associated transcription factor, sex determining region box-2 and orthodentical homeobox-2. Human limbal neurospheres could be cultured to express NeuN, neurofilament and rhodopsin. Rats receiving saline or no injection underwent complete degeneration of the retinal outer nuclear layer after 3 weeks. In contrast, rats injected with human limbal neurospheres or retinal pigment epithelial cells maintained the outer nuclear layer for up to 6 weeks. Gene expression in transplanted limbal neurospheres was inconsistent with the production of mature retinal pigment epithelial or photoreceptor cells.
INTRODUCTION
Age-related macular degeneration (AMD) and inherited retinal diseases are the most common causes of blindness in Australia. 1, 2 Cell therapies for these diseases are being conducted in phase I clinical trials in the UK, 3 USA 4 and Japan. 5 Supported by three decades of work on Royal College of Surgeons (RCS) rat and human trials of macular translocation and autologous grafts, replacement of retinal pigment epithelial (RPE) cells to prevent photoreceptor degeneration and restore macular function has become a widely recognized approach in the treatment of retinal diseases such as AMD. 6 To date, efforts to rescue photoreceptors have been largely focused on transplantation of RPE derived from pluripotent stem cells. Early phase clinical trials demonstrated that subretinal transplantation of RPE cells derived from human embryonic stem cells was safely tolerated by patients 4 ; however, efficacy has yet to be demonstrated despite numerous trials (NCT01344993, NCT02463344, NCT01345006, NCT02445612, NCT02590692, NCT02563782, NCT02286089).
In addition to RPE cell replacement, transplantation of mesenchymal and neural progenitor cells into the subretinal space has been shown to be an effective strategy for preventing photorecepotor cell death inanimal models of retinal degeneration. Multipotentstem cells derived from fetal forebrain (NCT01632527, NCT02467634, Stem Cell Inc., USA), umbilical tissue (NCT01226628, Janssen R&D, USA) and retinal progenitor cells (NCT02464436, MEEI/ReNeuron, USA) are currently being assessed in cell therapy clinical trials for the treatment of AMD and inherited retinal diseases, supported by encouraging preclinical data. 7 The efficacy of these allogeneic stem cell lines requires the use of immunosuppressive drugs to prevent rejection of donor cells in the eye. It is notable that all previous attempts to correct AMD using allogeneic RPE cells (such as fetal or cadaveric RPE) failed because of the rejection of the donor cells. 6 To address the issue of rejection, RPE cells could be sourced from induced pluripotent stem cells (iPSC), which can be reprogrammed from the patients' own fibroblasts and differentiated into RPE cells in a similar manner to human embryonic stem cells. 8 However, a recent clinical trial using iPSC-derived RPE cells was halted because of safety concerns arising from mutations detected in reprogrammed cell lines. 9 Although the trial has since resumed, it is now using well-characterized allogeneic iPSC lines. In recognition of the unmet clinical need for an accessible source of autologous stem cells for retinal cell replacement therapies, we have examined stem cells in the human corneoscleral limbus.
The human limbus is a specialized stem cell niche located on the surface of the eye at the junction between the transparent cornea and the opaque sclera. At the limbus, invaginations of the corneal epithelium into the limbal stroma form structures known as the Palisades of Vogt. Limbal palisades contain limbal epithelial stem cells (LESCs) that produce the migrating keratinocyte progenitor cells that replenish the corneal epithelium. 10 In addition to LESCs, the limbus contains a population of mesenchymal stem cells (LMSC). LMSC are closely associated with LESCs in the limbal niche. 11, 12 They are derived from the neural crest and are largely quiescent, dividing occasionally to replenish the keratocytes in the corneal stroma. Like other mesenchymal stem cells, LMSC are multipotent, with the potential for induction into neural, chondrocyte, osteocyte and adipocyte lineages. [13] [14] [15] Limbal stem cells represent an accessible source of autologous stem cells with a well-established clinical track record in the treatment of limbal stem cell deficiencies. 16, 17 Several studies have shown that dissociated limbal cell suspensions produce floating neurospheres when cultured in the presence of epidermal growth factor (EGF) and basic fibroblast growth factor (FGF2). Neuronal differentiation and photoreceptor gene expression were previously reported in rodent limbal neurosphere (LiNS) cultures, 18, 19 suggesting these cells can adopt a retinal progenitor phenotype.
The culture of retinal progenitors from an accessible adult stem cell source such as the limbus could provide a useful source of autologous cells for retinal cell therapies. Therefore, we have examined adult human LiNS as a candidate donor cell for retinal cell therapies by subretinal transplantation into the RCS rat, a model of RPE dystrophy simulating the disease process of AMD.
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METHODS
Human eye tissues
Human corneoscleral limbal rims and posterior cups were obtained from the Lions Eye Bank, Western Australia. The use of human tissue for research was approved by the University of Western Australia Human Research Ethics Office (Trial number: 2012-090).
Limbal neurosphere culture
We obtained surplus limbal rim tissue 1-4 days after removal of the central cornea for transplantation. During corneal transplantation, the button is trephined and the surplus rim tissue was returned to the Eye Bank. Limbal rims were stored at 37°C /5% CO 2 in Organ Culture Media (Minimum Essential Media, MEM, with 10% fetal calf serum, GlutaMAX and Antibiotic/Antimycotic supplements) for 3 weeks after enucleation before dissection and culture (mean time in storage: 23.6 days). During transport of donor limbal rims, 5% dextran was added to the media. Donor ages ranged from 22 to 72 years of age. To isolate limbal cells, the limbal region was dissected from the corneoscleral surface, cut into small pieces and incubated in neural stem cell media (NSM, Knockout DMEM-F12 with StemPro Neural Supplement) containing 200 U/mL collagenase IV overnight at 37°C. Primary dissociated limbal cells were seeded at low density (>20 cells/μL) into NSM supplemented with EGF (20 ng/mL), FGF2 (20 ng/mL) and human recombinant Noggin (100 ng/mL). Media was changed every 2-3 days.
To promote differentiation in vitro, primary LiNS were seeded onto geltrex-coated chamber slides after 1 week in suspension culture. The following day, EGF, FGF and Noggin were withdrawn from the media and replaced with brain-derived neurotrophic factor (100 ng/mL) or retinoic acid (0.6 μM) and FGF2 (5 ng/mL) and LiNS cultured for a further 1-2 weeks.
Primary human retinal pigment epithelial culture
Unless otherwise specified, media, medium supplements and reagents used for cell cultures were purchased from Thermo Fisher Scientific, Gibco (Waltham, MA, USA).
Human posterior eye cups were obtained from the Lions Eye Bank within 12 h after enucleation. After removal of the neuroretina from the posterior eye cup, RPE cells were gently scraped from the surface of the choroid. The retina was placed into RNAlater (Qiagen, Hilden, Germany) for isolation of RNA. Isolated RPE was rinsed in phosphate-buffered saline (PBS) before plating onto geltrex coated 12-well plates and culturing in Dulbecco's modified eagle's medium supplemented with 20% fetal calf serum. Human RPE was cultured for 4 weeks before transplantation or mRNA extraction.
Immunostaining
Cells were fixed with 4% paraformaldehyde in PBS for 15 min at 37°C then washed three times with PBS. Cells were then incubated with chilled methanol (À20°C) for 10 min at room temperature and washed in PBS again. Cells were incubated with blocking buffer (PBS, 5% goat serum, 0.3% Triton-X100) for 1 h at room temperature. Primary antibodies were diluted in blocking buffer and added to the cells for overnight incubation at 4°C. Cells were then washed with PBS before the addition of fluorophoreconjugated secondary antibodies and the nuclear stain 4 0 ,6-diamidino-2-phenylindole (DAPI, 1 μg/ mL, Sigma-Aldrich, St. Louis, MO, USA 
Royal College of Surgeons rats
In this study, we used rats from the non-pigmented, dystrophic RCS (rdy-) and the congenic, nondystrophic RCS-rdy + strain. 22 All experiments involving animals were approved by the University of Western Australia Animal Ethics Committee (RA/3/ 100/1330).
Subretinal injections
To prepare cells for injection, LiNS from two to six donors were pooled after 2-4 weeks of culture. Human RPE cultures from single donors were harvested after 4 weeks of culture. Human LiNS or RPE cells were dissociated with TrypLE Express (Thermo Fisher Scientific), washed once in PBS and counted using a hemocytometer. Cells were then pelleted and resuspended in saline at 200 000 cells/μL and stored on ice until injection. For injection of whole LiNS, an aliquot of the LiNS culture was dissociated and counted to determine cell numbers in the undissociated LiNS suspension.
Subretinal injections were performed as previously described. 8 To prevent rejection of xenogenic human donor cells, rats were immunosuppresed with cyclosporine (210 mg/L in drinking water), beginning 48 h before surgery. Three-week-old animals were anaesthetized using ketamine and medatomidine. Using an operating microscope, the eye was proptosed by a lasso suture loop behind the globe. Superior conjunctival peritomy was performed, and an intra-scleral pocket was made at the equator, avoiding the vortex veins, using a 32-gauge needle. Cells or saline were delivered via a single injection from a Hamilton syringe fitted with a 35-gauge blunt-ended needle that was placed in the scleral pocket and advanced carefully through the thin choroid into the subretinal space. For LiNS (n = 11 eyes, seven rats) or RPE (n = 5 eyes, three rats) transplants, approximately 200 000 cells were delivered in 1 μL of saline. For sham comparator, 1 μL of saline was injected (n = 10 eyes, eight rats). For unoperated controls, rats received immunosuppression but not subretinal injections (n = 10 eyes, nine rats). After injection, the conjunctival peritomy was closed with a dissolvable 7-O vicryl suture (Ethicon, Somerville, NJ, USA).
Optical coherence tomography and quantitation of retinal thicknesses
Post injection, retinal degeneration rescue was monitored using the Bioptigen optical coherence tomography (OCT) system (Bioptigen, Morrisville, NC USA). Retinal imaging was performed at 10 days and 3, 4 and 6 weeks after injection. Some animals were also imaged immediately before and 1 day after injection. Quantification of retinal thicknesses was performed in the superior quadrant of each eye. Inner and outer nuclear layer thicknesses were determined using Image-J. For each eye, retinal layer thicknesses were measured in B-scans from three different areas of the superior quadrant and averaged to obtain mean retinal layer thicknesses at each time point. Statistical analyses were performed using a two-tailed t-test. P-values were calculated at each timepoint by comparing mean outer nuclear layer (ONL) thicknesses in LiNS or RPE-injected rats with saline-injected controls.
Retinal histology and quantitation of retinal thicknesses
At the conclusion of the final imaging session, rats were euthanased with an intracardiac injection of pentobarbitone, performed under anaesthesia. Cornea's were marked at the 12 o'clock position to maintain orientation during processing and sectioning. Eyes were enucleated, punctured at the cornea and fixed in 4% paraformaldehyde for 30 min at room temperature, followed by 24-48 h at 4°C. Eyes were then transferred to PBS containing 30% sucrose. Some eyes were embedded in Tissue-Tek optimal cutting temperature compound (Sakura Finetek Torrance, CA, USA) and frozen for cryosectioning and immunostaining. Others were processed for paraffin embedding, sectioning and hemotoxylin/eosin staining. For hemotoxylin and eosin (H&E) staining, sections were submerged in Gill's haematoxylin for 3 min followed by three water washes. Wells were then stained in Scott's solution for 3 min (followed by three water washes) then in eosin solution for 2 min (followed by three water washes). Microscopy was performed on an Olympus IX70 inverted fluorescence microscope and imaged using Olympus DPController 3.1.1.267 acquisition software (Olympus). Images shown in Figures 3 and 4 were collected from the superior quadrant. ONL thicknesses in histological images were performed using Image J software. Statistical analyses were performed using a twotailed t-test. 
Western blot
RESULTS
Retinal gene expression in limbal neurosphere cultures
Dissociated human limbal cells cultured in neural stem cell media containing EGF, FGF2 and Noggin formed LiNS within 7-10 days (Fig. 1a) . LiNS had diameters ranging between 50 and 200 μm and could be passaged to produce new LiNS (Fig. 1a) . To examine gene expression in LiNS cells, neurospheres were plated onto geltrex-coated slides and cultured for 1 week in neural stem cell media supplemented with EGF, FGF2 and Noggin. LiNS displayed immunoreactivity for the neural lineage markers nestin, SOX2 and Ncadherin, as well as the retinal transcription factor RAX (Fig. 1b-d) . Expression of MITF (59 kDa), OTX2 (32 kDa) and RAX (38 kDa) proteins by LiNS cells was demonstrated by western blotting (Fig. S1 ).
Human limbal neurosphere expressed rhodopsin after culture in vitro
Limbal neurosphere cultured for 1 week in media supplemented with brain-derived neurotrophic factor gave rise to neuronal-like cells expressing NeuN and neurofilament (Fig. 1e) . To promote retinal phenotype, we cultured LiNS in neural stem cell media with retinoic acid and FGF2. After 2 weeks, neuronal cells co-expressing NeuN and rhodopsin were detected by immunostaining (Fig. 1f) . These results indicate that the neuronal and retinal differentiation potential previously reported in rodent LiNS 18 may be conserved in human LiNS.
Subretinal transplantation of human limbal neurosphere in Royal College of Surgeons rats
To examine the therapeutic potential of human LiNS for retinal cell therapy, we performed subretinal injections in a commonly employed model of RPE LiNS were plated onto geltrex after 1 week of suspension culture. The following day, epidermal growth factor, fibroblast growth factor (FGF2) and Noggin were removed from the media and replaced with brain-derived neurotrophic factor (e) or retinoic acid and FGF2 (f). After 1 week of culture with brain-derived neurotrophic factor, LiNS cells adopted a neuronal cell phenotype expressing NeuN and neurofilament immunoreactivity (e; green and red, respectively). After 2 weeks of culture in the presence of retinoic acid and FGF2, LiNS cells expressed NeuN and the photoreceptor marker rhodopsin (f; green and red, respectively). Scale bars in (b-f) indicate 50 μm.
dystrophy: the RCS rat. The RCS rat harbors a mutation in the MerTK gene that impairs the uptake of photoreceptor outer segments by host RPE cells. RPE failure in these animals leads to secondary photoreceptor degeneration, beginning in the third week of life and resulting in complete loss of the ONL by 7-9 weeks of age (Fig. 2a-b) . We examined retinal degeneration in individual RCS rats from 1 to 6 weeks after subretinal injection using OCT imaging. At the time of injection, the thickness of the ONL was 80-90% that of the congenic RCS-rdy + control strain (Fig. 2a,j) , which has a functional MerTK gene and does not undergo retinal degeneration. RCS rats receiving no surgery (Fig. 2b) or a sham surgery consisting of a subretinal injection of saline (Fig. 2c ) underwent rapid degeneration of the ONL, with complete loss of the ONL by 4 weeks post-injection (7 weeks of age). In contrast, subretinal injection of either human LiNS (Fig. 2d-f ) or human RPE cells (Fig. 2g-i) prevented the loss of the ONL in the region of the graft. Quantitation of ONL thicknesses in situ showed LiNS prevented ONL thinning in the superior retina with efficacies comparable with human RPE cells. ONL thickness was significantly increased in rats receiving human LiNS or RPE cells at 3 (P < 0.05), 4 and 6 (P < 0.01) weeks post injection, compared with saline-injected rats (Fig. 2j) . In most cases, whole LiNS were injected; however, in four eyes (three animals), LiNS were injected as single cell suspensions. No significant differences in ONL thicknesses were detected between animals receiving LiNS as whole spheres or as single cells, either at 3 or 6 weeks post injection (Fig. S2) .
Optical coherence tomography imaging 1 day after injection revealed whole LiNS could be introduced into the subretinal space (Fig. 3a) . We performed histological analyses on retinal cryosections 4 days post injection. In cryosections stained with the nuclear marker DAPI (Fig. 3b) or with H&E (Fig. 3c) , whole LiNS could be identified in the subretinal space. By 4 days post injection, subretinal LiNS were adhering to the host RPE layer (Fig. 3c-d) . Immunostaining for the RPE marker CRALBP labelled host RPE cells, and whole LiNS displayed little CRALBP immunoreactivity (Fig. 3d) .
Consistent with our OCT measurements, retinal sections from rats injected with human LiNS or RPE cells retained photoreceptor cells in the ONL for up to 6 weeks after injections (Fig. 4a,d,e,g ). In the superior retina, rescued areas typically extended for over 2 mm in rats injected with human LiNS or RPE cells, in some cases extending from the periphery to the optic nerve head (Fig. S3) .
In contrast, the ONL was largely degenerated in the inferior retina (Fig. S3 ) and in rats receiving no (Fig. 4b,e,h ) or sham surgeries (Fig. 4c,f,i) at these time points, with few remaining photoreceptor nuclei present from 4 to 6 weeks after injection. Pigmented human RPE cells could be identified in the subretinal space of injected non-pigmented rats (Fig. 4f) . Whole human LiNS were identified in the subretinal space 6 weeks after injection (Fig. 4j-k) . Immunostaining retinal sections for human-specific mitochondrial antigens demonstrated the presence of human donor cells in LiNS 6 weeks after injection (Fig. 4k) . Human donor cells were also observed interspersed with the host RPE layer (Fig. 4l) . Immunostaining of serial sections demonstrated that human LiNS were surrounded by activated, Iba1-positive microglial cells (Fig. 4m) and did not express the RPE marker CRALBP (Fig. 4n) . Deposits of rhodopsin immunoreactivity were observed in the interior of donor LiNS, which may indicate uptake of host photoreceptor outer segments by LiNS cells (Fig. 4o) .
Quantitation of ONL thicknesses in the superior retina of H&E-stained retinal sections demonstrated significantly increased mean ONL thicknesses in rats receiving human LiNS or RPE cells (36.8 ± 2.5 and 28.9 ± 6.7 μm, respectively) compared with rats receiving saline (4.8 ± 2.7 μm, **P < 0.01). No significant differences were found between LiNS and RPE-injected rats or between saline and uninjected controls (3.4 ± 2.8 μm) (Fig. 5) .
Together, these results indicate that human LiNS cells can engraft and survive in the retinal microenvironment and promote photoreceptor survival in a rat model of retinal dystrophy.
DISCUSSION
The development of cell therapies for blinding retinal diseases is at the forefront of regenerative medicine research. Current efforts directed at the clinical translation of stem cell technologies for the treatment of retinal diseases such as AMD are limited by a focus on allogeneic donor cell sources. Because strategies employing allogeneic cells rely on immunosuppression for efficacy and previous attempts using allogeneic sources of RPE cells have been unsuccessful in the treatment of AMD, 6 a source of autologous donor cells would be highly advantageous for the development of retinal cell therapies. In this study, we have demonstrated that human LiNS can prevent retinal degeneration after transplantation into the subretinal space of RCS rats.
Expression of neural and retinal lineage markers in human limbal neurospheres
The induction of rat limbal stem cells into the neural lineage was first reported in 2002. 23 Rodent limbal cell suspensions formed floating neurospheres when cultured in the presence of EGF, FGF2 and Noggin 4 (h) and 6 (i) wpi. (j) ONL thicknesses were measured in OCT images from RCS rat eyes injected with HuLiNS (n = 11), HuRPE (n = 5) or saline (n = 10) as well as rats receiving no surgery (n = 10). Each data point shows the mean ONL thickness for each group, expressed as a percentage of ONL thickness measured in the non-dystrophic RCSrdy rat retina. Error bars show the standard error of the mean for each group. ONL thickness was significantly increased in rats receiving human LiNS or RPE cells at 3 (*P < 0.05), 4 and 6 (**P < 0.01) wpi, compared with saline injected rats.
and were shown to differentiate to produce neuronal-, astroglial-and oligodendrocyte-like cells. 19, 23 Later, rodent LiNS generated in the absence of Noggin were shown to differentiate into functional neurons displaying electrical activity. 24 Although some studies showed that LiNS are derived from the neural crest-derived LMSCs, 15, 24 others have demonstrated that both LESC and LMSC can be incorporated into LiNS and that the expression of stem cell markers is increased when both stem cell types are present. 15 In the present work, we have cultured LiNS from human limbal cell suspensions in serum-free media containing EGF, FGF2 and Noggin because the inclusion of Noggin in the media was previously shown to increase the numbers of SOX2 expressing cells in rat LiNS cultures. 19 Consistent with previous studies, we demonstrate the expression of neural lineage markers SOX2, Nestin and N-cadherin in human LiNS as well as the adoption of a neuronal-like cell phenotype expressing NeuN and neurofilament (Fig. 1) . These results indicate that the neural lineage induction previously demonstrated in rodent LiNS 19, 23, 25 is conserved in human LiNS. Coculture of mouse LiNS with neonatal rat retinal cells was previously shown to induce expression of photoreceptor lineage marker rhodopsin. 18 Following subretinal injection into the mouse eye, transplanted mouse LiNS cells displayed immunoreactivity to recoverin and rhodopsin. In contrast, LiNS generated from aged human donors (up to 97 years of age) failed to produce rhodopsinexpressing cells either in vitro or in vivo after transplantation into the mouse retina. Instead, : At 6 wpi, the ONL was preserved in RCS rats injected with HuLiNS (g). In contrast, the ONL in unoperated (h) and saline-injected (i) rats was degenerated at 6 wpi. (h-i) Whole HuLiNS were identified in the subretinal space 6 wpi. (j-l) Serial retinal sections from an RCS rat injected with HuLiNS were stained with H&E (j; image depicts RPE and choroid inferior to the retina shown in g) or immunostained for human mitochondria (k; red signal shows human donor cells in the rat retina), the microglial/macrophage marker Iba1 (m; red), the RPE marker CRALBP (n; green) or the photoreceptor protein rhodopsin. Retinal sections were counterstained with the nuclear marker DAPI (k-o; blue).
In the present study, we have generated LiNS from donors aged from 22 to 72 years of age in the presence of Noggin and demonstrate expression of SOX2, RAX, MITF and OTX2 protein in human LiNS cultures (Fig. 1, Fig. S1 ). LiNS from working aged donors adopted neuronal cell phenotype expressing NeuN and rhodopsin in vitro (Fig. 1f) . Because coexpression of these markers is not usually observed in vivo, it is likely the rhodopsin positive cells reported here and elsewhere 18 represent an intermediate or immature neural progenitor phenotype, rather than a mature photoreceptor.
Consistent with the results of Chen et al. (2014) 18 in mice, we did not observe any human donor cells migrating into the rat retina. Instead, human LiNS adhered to the host RPE layer and spread out horizontally (Figs 3, 4k-l). Although human LiNS expressed the transcription factors MITF and OTX2, we did not detect any CRALBP (Fig. 4n) or RPE65 expression in transplanted LiNS, suggesting that mature RPE cells were not produced from human LiNS. Rhodopsin immunoreactivity was observed in transplanted human LiNS (Fig. 4o) ; however, it remains unclear as to whether this was the result of expression from human donor cells or of uptake of rat photoreceptor outer segments by LiNS cells or by host macrophages. These results indicate that although human LiNS express a range of retinal progenitor transcription factors, they did not produce mature photoreceptor or RPE cells after transplantation into the dystrophic rat retina.
Human limbal neurospheres prevent retinal degeneration in Royal College of Surgeon rats
Subretinal injection of human LiNS or RPE cells prevented retinal degeneration in dystrophic RCS rats (Fig. 2) . Both LiNS and RPE cells reduced the rate of photoreceptor cell loss in the first 3 weeks after injection, with stabilization of ONL thicknesses from 4 to 6 weeks after injection. Areas of rescue were limited to the superior retina, in which donor cells were found to be surviving up to 6 weeks after injection (Fig. 4f,j-l, Fig. S3 ). Rescue of the ONL in RCS rats has been reported after subretinal transplantation of a number of donor cell types, including fetal and adult RPE cells, 26, 27 RPE produced from pluripotent stem cells 8, 28 and non-RPE cell types, including neural and mesenchymal stem cells. [29] [30] [31] Interestingly, it was shown that human fetal forebrain progenitors formed a non-pigmented monolayer in the subretinal space, phagocytosed photoreceptor outer segments and prevented retinal degeneration in the RCS rat. 32 This suggests that neural progenitors may adopt an RPE-like phenotype in the subretinal microenvironment, providing neurotrophic support as well as some degree of clearance of photoreceptor debris from the subretinal space. In the data presented here and elsewhere, 18 LiNS spread across and integrated with the host RPE layer. Rhodopsin immunoreactivity observed within LiNS cells could indicate uptake of photoreceptor outer segments; however, further studies are necessary to determine whether transplanted LiNS participate in uptake of photoreceptor outer segments or mediate their therapeutic benefits solely through neurotrophic support.
Concluding remarks
In summary, we have shown that human limbal stem cells can be induced into a neural progenitor phenotype expressing retinal lineage markers. Transplantation of undifferentiated human LiNS prevented retinal degeneration in the RCS rat, demonstrating that these cells can engraft in the subretinal space and provide support to the dystrophic retina. Together with the relative accessibility of limbal stem cells, the derivation of retinal progenitor cells from human LiNS could provide a simpler alternative to iPSC as a donor cell source for autologous retinal cell therapy applications, such as the treatment of AMD and other retinal disorders. Figure 5 . Quantitation of outer nuclear layer thickness in histological images. Outer nuclear layer thicknesses were measured in the superior retina of hemotoxylin and eosin stained retinal sections from rats 6 weeks after injection. Subretinal injection of human limbal neurosphere (LiNS) or retinal pigment epithelial (RPE) cells significantly increased mean outer nuclear layer (ONL) thicknesses (36.8 ± 2.5 and 28.9 ± 6.7 μm, respectively) compared with injection of saline (4.8 ± 2.7 μm, **P < 0.01). No significant differences were found between LiNSand RPE-injected rats or between saline and uninjected controls (3.4 ± 2.8 μm). Mean ONL thicknesses in non-dystrophic rats (RDY) were 52.7 μm.
SUPPORTING INFORMATION
Additional Supporting Information may be found online in the supporting information tab for this article. Figure S1 . Western Blot Analysis of Human LiNS. 20 μg of total protein lysate from a cultured human RPE cell line (ARPE19) or LiNS cells were analyzed for MITF (59 kDa), OTX2 (32 kDa), and RAX (38 kDa) protein expression by western blot. Figure S2 . Comparison of Whole LiNS and Single Cells Injections. Measurements of ONL thicknesses in OCT images revealed no significant differences at 3 or 6 wpi between rats injected with whole LiNS (n = 5) or those injected with single cell suspensions (n = 4) of dissociated LiNS. Figure S3 . Retinal Histology. Low magnification images of H&E stained retinal sections from dystrophic RCS rats injected with human LiNS (A), RPE (B) cells or receiving no injection (C). Large areas of rescue could be seen in the superior retina of rats injected with human LiNS or RPE cells. Insets in A show the absence of an ONL in the inferior retina (top right) and preserved ONL in the superior retina (lower left). The ONL was absent in dystrophic RCS rats receiving no injection (C). Scale bars indicate 1 mm. 
